Pulmonary Function Testing in Patients with Tracheostomies: Feasibility and Technical Considerations
Sign Up to like & getrecommendations! Published in 2021 at "Lung"
DOI: 10.1007/s00408-021-00441-x
Abstract: Pulmonary function testing (PFT) in patients with tracheostomies has been perceived as difficult to perform and clinically unreliable. We studied the feasibility, quality, repeatability and clinical significance of PFT. Patients with tracheostomies that underwent PFT… read more here.
Keywords: testing patients; patients tracheostomies; function testing; pulmonary function ... See more keywords
PD-L1 Testing in Patients with Breast Cancer: Controversies and Current Practice
Sign Up to like & getrecommendations! Published in 2019 at "Current Breast Cancer Reports"
DOI: 10.1007/s12609-019-00340-4
Abstract: Atezolizumab has emerged as a novel treatment in patients with triple-negative breast cancer showing unprecedented survival gain. This breakthrough benefit is exclusively observed in PD-L1-positive patients, but PD-L1 positivity still lacks a reliable definition. In… read more here.
Keywords: testing patients; patients breast; breast cancer; practice ... See more keywords
CHRONIC DEFIBRILLATION THRESHOLD TESTING IN PATIENTS UNDERGOING SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR GENERATOR CHANGE
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)31165-7
Abstract: Defibrillation threshold (DFT) testing is recommended in patients undergoing initial subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation. There are little to no data on chronic DFT testing in patients undergoing S-ICD generator change at the end of… read more here.
Keywords: testing patients; subcutaneous implantable; patients undergoing; implantable cardioverter ... See more keywords
A 2020 update on the use of genetic testing for patients with primary immunodeficiency
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2020.1814145
Abstract: ABSTRACT Introduction Genetic testing of patients with clinically diagnosed or suspected primary immunodeficiencies (PIDs) constitutes standard of care. Choice of testing modality and patient attributes can impact the likelihood of securing a diagnosis. Areas covered… read more here.
Keywords: gene panel; suspected pids; testing patients; genetic testing ... See more keywords
Verification of the machine delivery parameters of treatment plan via deep learning.
Sign Up to like & getrecommendations! Published in 2020 at "Physics in medicine and biology"
DOI: 10.1088/1361-6560/aba165
Abstract: We developed a generative adversarial network (GAN)-based deep learning approach to estimate the multileaf collimator (MLC) aperture and corresponding monitor units (MUs) from a given three dimensional (3D) dose distribution. The proposed design of adversari-al… read more here.
Keywords: deviation; testing patients; learning; treatment ... See more keywords
Recommendations for laboratory testing of UK patients with acute myeloid leukaemia
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18516
Abstract: University Hospitals of Bristol and Weston NHS FoundationTrust, Bristol, UK Oncology Cytogenetics, The Christie NHS Foundation Trust, Manchester, UK Bristol Genetic Laboratory, North Bristol NHS Trust, Westbury on Trym, UK Cancer Genetics Laboratory, Department of… read more here.
Keywords: university; laboratory testing; recommendations laboratory; patients acute ... See more keywords
S100 Utility of endobronchial ultrasound-guided transbronchial needle aspiration for pd-l1 testing in patients with nsclc
Sign Up to like & getrecommendations! Published in 2017 at "Thorax"
DOI: 10.1136/thoraxjnl-2017-210983.106
Abstract: Rationale Recent data have demonstrated the superiority of Pembroluzimab over chemotherapy for patients with advanced NSCLC and high (≥50% expression) of PD-L1.1 This has resulted in NICE approving Pembroluzimab as a first line treatment option for… read more here.
Keywords: testing patients; s100 utility; patients nsclc; high expression ... See more keywords
Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Respiratory and Critical Care Medicine"
DOI: 10.1164/rccm.202204-0762le
Abstract: DOI: 10.1164/rccm.202107-1769OC. 2. Stock CJW, Hoyles RK, Daccord C, Kokosi M, Visca D, De Lauretis A, et al. Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression. Respirology 2021;26:461–468.… read more here.
Keywords: walk testing; remote minute; validation; patients pulmonary ... See more keywords
Changing the landscape of germline testing in patients with pancreatic adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.4_suppl.676
Abstract: 676Background: Results from the POLO trial demonstrated the benefits of PARP inhibition in patients (pts) with germline BRCA-mutated metastatic pancreatic cancer (PC). In 2018, ASCO and NCCN update... read more here.
Keywords: testing patients; landscape germline; pancreatic adenocarcinoma; germline testing ... See more keywords
Circulating tumor DNA (ctDNA) as a tool to help guide germline testing in patients with solid malignancies.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.10602
Abstract: 10602 Background: As the use of circulating tumor DNA (ctDNA) is more widely implemented, incidental identification of pathogenic variants reflecting germline alterations in cancer predisposition genes will occur more frequently. Such mutations are expected to… read more here.
Keywords: testing patients; germline; high maf; germline testing ... See more keywords
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
Sign Up to like & getrecommendations! Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0184178
Abstract: Background There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of… read more here.
Keywords: testing patients; qft; patients psoriasis; quantiferon gold ... See more keywords